Exscientia PLCNASDAQ:EXAI
- LAST PRICE8.8900
- TODAY'S CHANGE (%)0.5600 (6.7227%)
- Bid / Lots8.8300/ 5
- Ask / Lots8.9100/ 2
- Open / Previous Close8.3000 / 8.3300
- Day Range
- 52 Week Range
- Volume102,582
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EXAI |
|---|---|---|
| 09:32 ET | 7514 | 8.33 |
| 09:34 ET | 2042 | 8.44 |
| 09:38 ET | 473 | 8.21 |
| 09:39 ET | 200 | 8.33 |
| 09:41 ET | 1400 | 8.6 |
| 09:43 ET | 1500 | 8.72 |
| 09:45 ET | 400 | 8.64 |
| 09:52 ET | 811 | 8.535 |
| 09:54 ET | 1900 | 8.74 |
| 09:57 ET | 100 | 8.71 |
| 10:03 ET | 600 | 8.6784 |
| 10:10 ET | 750 | 8.75 |
| 10:12 ET | 700 | 8.85 |
| 10:17 ET | 500 | 8.788 |
| 10:21 ET | 700 | 8.8406 |
| 10:24 ET | 1200 | 8.85 |
| 10:28 ET | 300 | 8.865 |
| 10:30 ET | 200 | 8.9 |
| 10:32 ET | 200 | 8.89 |
| 10:33 ET | 694 | 8.9 |
| 10:35 ET | 200 | 8.87 |
| 10:46 ET | 100 | 8.9353 |
| 10:50 ET | 27862 | 8.99 |
| 10:51 ET | 1030 | 8.82 |
| 10:53 ET | 150 | 8.81 |
| 10:57 ET | 2514 | 8.84 |
| 11:00 ET | 479 | 8.87 |
| 11:02 ET | 400 | 8.85 |
| 11:04 ET | 700 | 8.835 |
| 11:06 ET | 100 | 8.87 |
| 11:08 ET | 100 | 8.83 |
| 11:09 ET | 100 | 8.86 |
| 11:11 ET | 375 | 8.88 |
| 11:13 ET | 552 | 8.9 |
| 11:15 ET | 1100 | 8.95 |
| 11:18 ET | 100 | 8.99 |
| 11:20 ET | 100 | 9.02 |
| 11:22 ET | 700 | 8.99 |
| 11:24 ET | 900 | 8.9926 |
| 11:26 ET | 1892 | 9 |
| 11:27 ET | 100 | 9.03 |
| 11:29 ET | 1894 | 9.1 |
| 11:31 ET | 600 | 9.06 |
| 11:38 ET | 150 | 8.99 |
| 12:12 ET | 1100 | 9.005 |
| 12:20 ET | 100 | 9.01 |
| 12:21 ET | 300 | 9.04 |
| 12:25 ET | 1200 | 9.01 |
| 12:34 ET | 100 | 8.945 |
| 12:36 ET | 2674 | 8.9 |
| 12:38 ET | 500 | 8.88 |
| 12:43 ET | 1200 | 8.7201 |
| 12:45 ET | 400 | 8.8702 |
| 12:48 ET | 600 | 8.84 |
| 12:52 ET | 1554 | 8.795 |
| 12:59 ET | 1419 | 8.78 |
| 01:01 ET | 1100 | 8.78 |
| 01:03 ET | 114 | 8.7883 |
| 01:06 ET | 900 | 8.825 |
| 01:08 ET | 200 | 8.837 |
| 01:12 ET | 426 | 8.85 |
| 01:19 ET | 1005 | 8.89 |
| 01:21 ET | 600 | 8.76 |
| 01:24 ET | 100 | 8.875 |
| 01:26 ET | 100 | 8.94 |
| 01:32 ET | 100 | 8.85 |
| 01:42 ET | 300 | 8.8999 |
| 01:48 ET | 100 | 8.88 |
| 01:53 ET | 350 | 8.88 |
| 02:08 ET | 700 | 8.85 |
| 02:11 ET | 117 | 8.865 |
| 02:13 ET | 1050 | 8.9099 |
| 02:27 ET | 100 | 8.8 |
| 02:47 ET | 2049 | 8.85 |
| 02:49 ET | 300 | 8.87 |
| 02:51 ET | 300 | 8.84 |
| 02:54 ET | 859 | 8.89 |
May 3, 2022
Exscientia to Present at the BofA Securities 2022 Healthcare Conference, from 4:30PM ET on Tuesday May 03, 2022 by Business Wire
4:30PM ET on Tuesday May 03, 2022 by Business Wire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Exscientia PLC | 836.5M | 0.0x | --- |
Keros Therapeutics Inc | 1.0B | -15.7x | --- |
Madrigal Pharmaceuticals Inc | 1.0B | -4.6x | --- |
Sana Biotechnology Inc | 1.0B | -2.4x | --- |
Axsome Therapeutics Inc | 1.0B | -8.2x | --- |
Immunitybio Inc | 1.1B | -4.4x | --- |
Company Information
Exscientia PLC, formerly Exscientia Ltd, is an artificial intelligence-driven pharmaceutical technology (pharmatech) company. The Company's focus is on the discovery, design and development of small molecule drug candidates. The Company has built a complete end-to-end solution of artificial intelligence (AI), and experimental technologies for target identification, drug candidate design, translational models and patient selection. Its AI process is comprised of the four elements: Precision Target, Precision Design, Precision Experiment and Precision Medicine. Its AI-design includes a range of deep learning and machine learning algorithms, generative methods, active learning and natural language processing. These methods are used to guide target selection, to design the precise molecular architecture of potential drug molecules and to analyze patient tissues to prioritize the molecules. The Company's lead drug candidate, EXS21546, is in early stage of development.
Contact Information
- Headquarters
- The Schrodinger Building Oxford Science ParkOXFORD, United Kingdom OX4 4GE
- Phone
- 186-581-8941
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $836.5M |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | 120.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | --- |
Book Value | $0.61 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
